Background: Although some clinical practice guidelines regarding hemodialysis recommend salt restriction, few studies have examined the association between salt intake and clinical outcomes in hemodialysis patients. This study aimed to clarify the association between salt intake and mortality in hemodialysis patients. Methods: This retrospective cohort study was based on the Japanese Society for Dialysis Therapy renal data registry database (2008) and included 88,115 adult patients who had received hemodialysis for at least 2 years. Estimated salt intake was the main predictor and was calculated from intra-dialytic weight loss and pre- and post-dialysis serum sodium levels. Nonlinear logistic regression was used to determine the association between salt intake and mortality, adjusting for potential confounders. The outcomes considered were all-cause mortality and cardiovascular death at 1 year. Results: The median (25–75th percentile) salt intake at baseline was 6.4 (4.6–8.3) g/day. At 1 year, all-cause mortality occurred in 1,845 (2.1%) patients, including 807 cardiovascular deaths. The low salt intake group (< 6 g/day) demonstrated the highest all-cause mortality and cardiovascular deaths. No association was observed between high salt intake, all-cause mortality and cardiovascular deaths. The lowest risk for all-cause mortality and cardiovascular death occurred among patients with an estimated salt intake of 9 g/day. Conclusion: Low salt intake, but not high salt intake, was associated with all-cause and cardiovascular mortality in Japanese hemodialysis patients. Further studies to justify including a lower limit of salt intake for hemodialysis patients are suggested.

1.
Fouque D, Vennegoor M, ter Wee P, Wanner C, Basci A, Canaud B, Haage P, Konner K, Kooman J, Martin-Malo A, Pedrini L, Pizzarelli F, Tattersall J, Tordoir J, Vanholder R: EBPG guideline on nutrition. Nephrol Dial Transplant 2007; 22(suppl 2):ii45–ii87.
2.
Taler SJ, Agarwal R, Bakris GL, Flynn JT, Nilsson PM, Rahman M, Sanders PW, Textor SC, Weir MR, Townsend RR: KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis 2013; 62: 201–213.
3.
[Dietary recommendations for chronic kidney disease, 2014]. Nihon Jinzo Gakkai Shi 2014; 56: 553–599.
4.
Tsuruya K, Fukuma S, Wakita T, Ninomiya T, Nagata M, Yoshida H, Fujimi S, Kiyohara Y, Kitazono T, Uchida K, Shirota T, Akizawa T, Akiba T, Saito A, Fukuhara S: Dietary patterns and clinical outcomes in hemodialysis patients in Japan: a cohort study. PLoS One 2015; 10:e0116677.
5.
Mok E, Tam B: Stressors and coping methods among chronic haemodialysis patients in hong kong. J Clin Nurs 2001; 10: 503–511.
6.
Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F, Fukuhara S, Young EW, Kurokawa K, Saito A, Bommer J, Wolfe RA, Held PJ, Port FK: Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003; 64: 339–349.
7.
Testa A, Beaud JM: The other side of the coin: Interdialytic weight gain as an index of good nutrition. Am J Kidney Dis 1998; 31: 830–834.
8.
Lindley EJ: Reducing sodium intake in hemodialysis patients. Semin Dial 2009; 22: 260–263.
9.
Hecking M, Karaboyas A, Antlanger M, Saran R, Wizemann V, Chazot C, Rayner H, Horl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Moissl U, Kotanko P, Levin NW, Saemann MD, Kalantar-Zadeh K, Port FK, Wabel P: Significance of interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol 2013; 38: 78–90.
10.
Mc Causland FR, Waikar SS, Brunelli SM: The relevance of dietary sodium in hemodialysis. Nephrol Dial Transplant 2013; 28: 797–802.
11.
Lee MJ, Doh FM, Kim CH, Koo HM, Oh HJ, Park JT, Han SH, Yoo TH, Kim YL, Kim YS, Yang CW, Kim NH, Kang SW: Interdialytic weight gain and cardiovascular outcome in incident hemodialysis patients. Am J Nephrol 2014; 39: 427–435.
12.
Cabrera C, Brunelli SM, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, Stalhammar NO, Stefansson BV: A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients. BMC Nephrol 2015; 16: 113.
13.
Inrig JK, Oddone EZ, Hasselblad V, Gillespie B, Patel UD, Reddan D, Toto R, Himmelfarb J, Winchester JF, Stivelman J, Lindsay RM, Szczech LA: Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int 2007; 71: 454–461.
14.
Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, Fonarow GC: Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 2009; 119: 671–679.
15.
Mc Causland FR, Waikar SS, Brunelli SM: Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients. Kidney Int 2012; 82: 204–211.
16.
Santos SF, Peixoto AJ: Sodium balance in maintenance hemodialysis. Semin Dial 2010; 23: 549–555.
17.
O’Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, McQueen M, Sleight P, Sharma AM, Dans A, Probstfield J, Schmieder RE: Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011; 306: 2229–2238.
18.
O’Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, Yan H, Lee SF, Mony P, Devanath A, Rosengren A, Lopez-Jaramillo P, Diaz R, Avezum A, Lanas F, Yusoff K, Iqbal R, Ilow R, Mohammadifard N, Gulec S, Yusufali AH, Kruger L, Yusuf R, Chifamba J, Kabali C, Dagenais G, Lear SA, Teo K, Yusuf S; PURE Investigators: Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 2014; 371: 612–623.
19.
Dong J, Li Y, Yang Z, Luo J: Low dietary sodium intake increases the death risk in peritoneal dialysis. Clin J Am Soc Nephrol 2010; 5: 240–247.
20.
Nakai S, Watanabe Y, Masakane I, Wada A, Shoji T, Hasegawa T, Nakamoto H, Yamagata K, Kazama JJ, Fujii N, Itami N, Shinoda T, Shigematsu T, Marubayashi S, Morita O, Hashimoto S, Suzuki K, Kimata N, Hanafusa N, Wakai K, Hamano T, Ogata S, Tsuchida K, Taniguchi M, Nishi H, Iseki K, Tsubakihara Y: Overview of regular dialysis treatment in Japan (as of 31 December 2011). Ther Apher Dial 2013; 17: 567–611.
21.
Kimura G, Kojima S, Saito F, Kawano Y, Imanishi M, Kuramochi M, Omae T: Quantitative estimation of dietary intake in patients on hemodialysis. Int J Artif Organs 1988; 11: 161–168.
22.
Ramdeen G, Tzamaloukas AH, Malhotra D, Leger A, Murata GH: Estimates of interdialytic sodium and water intake based on the balance principle: differences between nondiabetic and diabetic subjects on hemodialysis. ASAIO J 1998; 44: 812–817.
23.
Hecking M, Karaboyas A, Saran R, Sen A, Inaba M, Rayner H, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G: Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol 2012; 7: 92–100.
24.
Ahmad S: Dietary sodium restriction for hypertension in dialysis patients. Semin Dial 2004; 17: 284–287.
25.
Inrig JK, Patel UD, Gillespie BS, Hasselblad V, Himmelfarb J, Reddan D, Lindsay RM, Winchester JF, Stivelman J, Toto R, Szczech LA: Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis 2007; 50: 108–118. e1–4.
26.
Mills KT, Chen J, Yang W, Appel LJ, Kusek JW, Alper A, Delafontaine P, Keane MG, Mohler E, Ojo A, Rahman M, Ricardo AC, Soliman EZ, Steigerwalt S, Townsend R, He J; Chronic Renal Insufficiency Cohort Study Investigators: Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease. JAMA 2016; 315: 2200–2210.
27.
Robinson BM, Tong L, Zhang J, Wolfe RA, Goodkin DA, Greenwood RN, Kerr PG, Morgenstern H, Li Y, Pisoni RL, Saran R, Tentori F, Akizawa T, Fukuhara S, Port FK: Blood pressure levels and mortality risk among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int 2012; 82: 570–580.
28.
Moons KG, Donders RA, Stijnen T, Harrell FE Jr: Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol 2006; 59: 1092–1101.
29.
Rubin DB, Schenker N: Multiple imputation in health-care databases: an overview and some applications. Stat Med 1991; 10: 585–598.
30.
Psaty BM, Koepsell TD, Lin D, Weiss NS, Siscovick DS, Rosendaal FR, Pahor M, Furberg CD: Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 1999; 47: 749–754.
31.
Bao Y, Han J, Hu FB, Giovannucci EL, Stampfer MJ, Willett WC, Fuchs CS: Association of nut consumption with total and cause-specific mortality. N Engl J Med 2013; 369: 2001–2011.
32.
Hecking M, Karaboyas A, Saran R, Sen A, Horl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Port FK: Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2012; 59: 238–248.
33.
Kramer H, Yee J, Weiner DE, Bansal V, Choi MJ, Brereton L, Berns JS, Samaniego-Picota M, Scheel P Jr, Rocco M: Ultrafiltration rate thresholds in maintenance hemodialysis: An nkf-kdoqi controversies report. Am J Kidney Dis 2016; 68: 522–532.
34.
Cobb LK, Anderson CA, Elliott P, Hu FB, Liu K, Neaton JD, Whelton PK, Woodward M, Appel LJ; American Heart Association Council on Lifestyle and Metabolic Health: Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation 2014; 129: 1173–1186.
35.
Yang SC, Chiang CK, Hsu SP, Hung KY: Relationship between interdialytic weight gain and nutritional markers in younger and older hemodialysis patients. J Ren Nutr 2008; 18: 210–222.
36.
Sezer S, Ozdemir FN, Arat Z, Perim O, Turan M, Haberal M: The association of interdialytic weight gain with nutritional parameters and mortality risk in hemodialysis patients. Ren Fail 2002; 24: 37–48.
37.
Lopez-Gomez JM, Villaverde M, Jofre R, Rodriguez-Benitez P, Perez-Garcia R: Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int 2005; 67:S63–S68.
38.
Kopple JD: National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2001; 37:S66–S70.
39.
Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD: Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004; 80: 299–307.
40.
Hu F: Obesity Epidemiology: Interpreting Epidemiologic Evidence and causal inference in Obesity Research. Oxford University Press, 2008, pp 38–52.
41.
Liebman SE, Lamontagne SP, Huang LS, Messing S, Bushinsky DA: Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity. Am J Kidney Dis 2011; 58: 257–265.
42.
Liu K, Stamler J: Assessment of sodium intake in epidemiological studies on blood pressure. Ann Clin Res 1984; 16(suppl 43): 49–54.
43.
Lopes AA, Lantz B, Morgenstern H, Wang M, Bieber BA, Gillespie BW, Li Y, Painter P, Jacobson SH, Rayner HC, Mapes DL, Vanholder RC, Hasegawa T, Robinson BM, Pisoni RL: Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in hemodialysis patients: the DOPPS. Clin J Am Soc Nephrol 2014; 9: 1702–1712.
44.
Tentori F, Elder SJ, Thumma J, Pisoni RL, Bommer J, Fissell RB, Fukuhara S, Jadoul M, Keen ML, Saran R, Ramirez SP, Robinson BM: Physical exercise among participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS): correlates and associated outcomes. Nephrol Dial Transplant 2010; 25: 3050–3062.
45.
Watanabe H, Sasatani M, Doi T, Masaki T, Satoh K, Yoshizumi M: Protective effects of Japanese soybean paste (miso) on stroke in stroke-prone spontaneously hypertensive rats (shrsp). Am J Hypertens 2018; 31: 43–47.
46.
Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270–3277.
47.
Mente A, O’Donnell M, Rangarajan S, Dagenais G, Lear S, McQueen M, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Li W, Lu Y, Yi S, Rensheng L, Iqbal R, Mony P, Yusuf R, Yusoff K, Szuba A, Oguz A, Rosengren A, Bahonar A, Yusufali A, Schutte AE, Chifamba J, Mann JF, Anand SS, Teo K, Yusuf S; PURE, EPIDREAM and ONTARGET/TRANSCEND Investigators: Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet 2016; 388: 465–475.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.